Nektar Therapeutics (NKTR) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$0.00

$0 (0%)

Last update: 07:00 PM EST

Day's range

$62.5

$69.49

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
05/11/2026	Wedbush	Martin Fan	$80.00	$81.89	-2.31%
05/08/2026	Piper Sandler	Yasmeen Rahimi	$192.00	$83.37	130.3%
03/13/2026	Oppenheimer	Jay Olson	$140.00	$73.27	91.07%
01/26/2026	Piper Sandler	Yasmeen Rahimi	$105.00	$36.35	188.86%
12/16/2025	Oppenheimer	Jay Olson	$115.00	$50.43	128.04%
11/24/2025	Jefferies	Roger Song	$121.00	$54.28	122.92%
09/18/2025	Jefferies	Roger Song	$99.00	$58.74	68.54%
04/17/2022	Mizuho Securities	Mara Goldstein	$6.00	$4.74	26.58%
02/28/2022	J.P. Morgan	Jessica Fye	$17.00	$10.98	54.83%
11/07/2021	Ladenburg Thalmann & Co.	Aydin Huseynov	$20.00	$14.65	36.52%
05/17/2021	Goldman Sachs	Chris Shibutani	$24.00	$18.13	32.38%

Nektar Therapeutics FAQ's

Nektar Therapeutics has been rated by research analysts at Wedbush, Piper Sandler, H.C. Wainwright, Oppenheimer, BTIG, Jefferies in the past 90 days.